XML 60 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Disclosures (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Significant Expense
The table below summarizes the significant expense categories regularly reviewed by the CODM for the three months ended March 31:


Three Months Ended March 31,
20252024
Operating expenses:
Clinical product candidates$17,781 $14,952 
Pre-clinical product candidates114 181 
Employee costs- research and development2,167 2,002 
Employee costs-general and administrative1,560 1,357 
Non-cash stock compensation2,042 2,741 
Depreciation expense43 26 
Professional fees and other segment expenses3,118 2,622 
Total operating expenses26,825 23,881 
Loss from operations(26,825)(23,881)
Interest Income183 1,187 
Change in fair value of the tranche rights— (4,796)
Other income (expense)1,169 (2,094)
Net loss$(25,473)$(29,584)